Many pathological liver conditions, such as liver fibrosis, chronic hepatitis C, autoimmune hepatitis, and non-alcoholic fatty liver disease, show a strong correlation with TGF-β-related signaling. This evidence concerns the gene TGFB1 and chronic hepatitis C virus infection.